Objective: Associations between maternal glucose levels and increased foetal growth are well established, and independent relationships with maternal weight, weight gain and insulin resistance are also observed. The relative roles of lipolysis and glucose production in the determination of these observations remain unclear.
| INTRODUCTION
The metabolic environment during intrauterine life is known to influence health of the offspring. Impaired glucose tolerance in pregnancy, resulting from gestational, type 1 and type 2 diabetes, is associated with risk of macrosomia and may have important implications for risk of obesity and type 2 diabetes in the offspring. Data from the Hyperglycaemia and Adverse Pregnancy Outcome study (HAPO) have clearly shown a continuous linear relationship between maternal glucose levels and weight of the newborn infant.
1 Independent effects of maternal body mass index (BMI), 2 insulin resistance 3 and basal metabolic rate 4 have also been suggested as important factors in determining foetal growth.
As foetal overgrowth is common also in diabetic pregnancies with adequate glucose control, placental transfer of substrates other than glucose could be involved in determining weight and body composition of the foetus. 2, 5, 6 During pregnancy, levels of nonesterified fatty acids (NEFA), triacylglycerols and cholesterol increase in the circulation. These correlate positively with maternal BMI and insulin resistance as well as foetal macrosomia even in the absence of diagnosed gestational diabetes. 2, [7] [8] [9] There is only limited information on the relative roles of lipolysis and glucose production on foetal size. Thus, we performed a detailed physiological study in a cohort of healthy nondiabetic women with varying levels of glucose tolerance, focusing on the relative importance of maternal rates of lipolysis and glucose production for foetal growth.
| METHODS

| Subjects
Subjects were recruited from the Cambridge Baby Growth Study, a study of maternal and early childhood growth and development.
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The women were approached at 28 weeks of gestation during a routine oral glucose tolerance test (OGTT), which is part of the Cambridge Baby Growth Study protocol, and from the gestational diabetes outpatient clinic at Rosie Maternity Hospital, Cambridge.
Written consent was obtained after oral and written information had been provided. The study was approved by the Local Research Ethics Committee, UK.
Dating of the pregnancies was performed by measurement of the crown rump length or biparietal diameter at routine ultrasound examination at 11-14 weeks of gestation. Twenty-one, nonsmoking normotensive nulliparous women, with mean age of 31.0±5.3 years and with variable levels of glycaemia at 28 weeks (120 minutes glucose levels 4.4-9.4 mmol/L, post-75 g OGTT), were recruited and were studied at 35.4±0.8 weeks of gestation. One woman was of South Asian descent, and the others were Caucasian. One woman had ulcerative colitis treated with mesalazine, and one woman had hypothyroidism treated with thyroxine; both conditions were well controlled at the time of the study. 
| Study design
| Assessment of the pregnant women
| Energy substrate production
| Resting energy expenditure
Resting energy expenditure was estimated from respiratory gas exchange measurements (GEMs) made by the GEM ventilated canopy indirect calorimetry system (GEM Nutrition, Daresbury, UK) with the woman resting and awake. The measurement was performed with the subject breathing 20-30 minutes through the instrument with a period of calibration with room air before and after the measurement.
Any deviation from zero in the room air measurements was used to refine the subject measurements, by on average −1.45% of the unadjusted resting metabolic rate (RMR).
| Maternal weight and body composition
Maternal weight was measured with electronic scales and height with a stadiometer.
Body mass index measured at booking was used as prepregnancy BMI.
Maternal body composition at 35 weeks was estimated using a three-compartment model combining measurements of body mass, total body water (TBW) mass and body volume in an expression derived by Siri. 12 During pregnancy, there is a lower density of the fat-free mass due to increased hydration 13 and the use of a twocompartment model would overestimate the fat mass. The threecompartment model assumes that the body consists of fat, water and fat-free dry mass (protein plus mineral).
Total body water measurement was carried out using stable iso-
O. 14 The tracer used for TBW measurement was
O water with a concentration of 10% supplied by CortecNet, Paris, France. After baseline measurements of H 2
18
O in saliva, a drink of H 2
O was given and further saliva samples were taken after 3, 5 and 6 hours. The concentration of Oxygen-18 in each salivary sample was determined using isotope ratio mass spectrometry (IRMS).
Briefly, 0.4 mL samples were placed in 10 mL septum sealed vacutain- Oxygen.
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Body volume was measured by an air displacement plethysmograph (BODPOD® Cosmed USA Inc, Concord, CA, USA). 17 The measurement of body volume was assumed not to be affected by pregnancy.
After calibration the pregnant woman entered the chamber wearing a swimming suit and swim cap, and two body volume assessments were made. If the difference between the two measurements was >150 mL, a third measurement was performed and the mean of the two measurements with the best agreement was used in the calculation. Thoracic gas volume was estimated by the BODPOD® software.
The software corrects the measured volume for thoracic volume and for surface area effects, yielding % fat and body mass data, computed by a Siri two-compartment expression. 18 This expression was backcalculated to yield net body volume for the three-compartment model calculation.
| Estimated foetal weight, and infant birthweight
Foetal weight was estimated by ultrasound examination at 34-36 weeks of gestation and calculated from measurements of biparietal diameter, head circumference, femoral length and abdominal circumference using the four-parameter Hadlock model. 19 The infant weight was measured at delivery. Sex-and gestational age-independent standard deviation scores (SDS) for weight was calculated by comparison with the 1990 British growth reference.
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| Biochemical analysis
Blood glucose concentrations were measured within 30 seconds after sampling using 25 μL whole-blood samples on a Y.S.I. model 2300
STAT Plus analyser (YSI (UK) Ltd, Fleet, UK).
Plasma insulin concentrations were measured using a DAKO ELISA (DAKO Ltd., Ely, UK) according to the manufacturer's instructions.
| Statistics
The results are presented as median and ranges as well as mean±SD.
Variables not normally distributed were transformed into common logarithms. Relationships between maternal glucose tolerance, rates of glucose and glycerol production, insulin levels, as well as measures of maternal body composition, estimated foetal weight and infant anthropometrics were performed using Pearson bivariate correlation tests. In multiple stepwise regression analysis, independent effects of variables important for estimated weight of the foetus, infant size and body composition at birth were tested. The variables in the regression analysis were chosen if significance was <.05 in bivariate analysis. Analyses were performed with the IBM SPSS program version 23
(IBM, Armonk, NY, USA). Correlations and differences were considered significant at P-values <.05.
| RESULTS
| Maternal, foetal and infant characteristics
The women were examined at 35 weeks±6 days, and until assessment, the median gestational weight gain was 13 (8.3-31) kg.
Estimated foetal weight at assessment averaged 2673±377 g. The infants were born at 40.3±1.0 weeks and their birthweights averaged 3502±493 g. Maternal rates of total hepatic glucose and glycerol production were 955±180 and 235±98 μmol/min, respectively. The maternal, foetal and infant characteristics and relationships between maternal weight gain, fat mass at 35 weeks and metabolic outcomes are summarized in Table 1 . At 35 weeks of gestation, total glucose and glycerol production rates were closely related to maternal weight, maternal fat mass, fat-free mass and resting energy expenditure (Table 2 ). Glucose and glycerol production rates were highly correlated (r=.61, P=.004), and both were related to maternal weight and fat mass at assessment. Total glucose production rate (GPR) was closely related to fasting insulin (r=.68, P=.001) ( Table 2) . Despite the wide range of maternal glycaemia as assessed by the OGTT at 28 weeks, these measures were not related to total glucose production or total glycerol production rates.
| Relationships between maternal metabolic variables and estimated foetal weight at 35 weeks of gestation and birthweight
Total glucose and glycerol production rates were closely corre- 
| DISCUSSION
In this cohort of pregnant women with a normal range of glucose tolerance, rates of maternal lipolysis and glucose production correlated with estimated foetal weight at 35 weeks of gestation. The combined effects of maternal energy substrate production explained more than 60% of the variance in estimated foetal weight which persisted after controlling for fasting insulin, resting energy expenditure, maternal size and body composition.
In late pregnancy, women increase their rate of hepatic glucose production by 16%-30% for the demands of the growing foetus.
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The rate of maternal glucose production in this study was strongly related to estimated foetal weight at 35 weeks of gestation. The production rate was comparable to that found in earlier studies of pregnant women in late gestation.
A novel finding of this study is the relationship between maternal lipolysis and estimated foetal weight. In pregnancy, although placental glucose delivery is a major factor driving foetal growth as a result of increased foetal insulin secretion and hepatic IGF-I production, glucose is not the only driver for foetal growth. 5 Previous studies have shown that increasing maternal insulin resistance in the third trimester increases the rate of lipolysis by 50% 11 and leads to an elevation of circulating triacylglycerols, which correlates with increased foetal growth.
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Although the placental transport of fatty acids and triacylglycerols is limited, the loss of maternal adipose tissue in late gestation has also been shown to be associated with the exponential foetal fat accretion and weight gain. 6 The results of this study are in keeping with these findings, confirming a relationship between rates of lipolysis and foetal growth.
There were no relationships between 28 weeks of fasting glucose or 120 minutes OGTT glucose level and glucose production or estimated foetal weight at 35 weeks. The utility of OGTT data at 28 weeks to evaluate glycaemic exposures during pregnancy has been questioned in studies of continuous glucose monitoring 26, 27 and by the results of the HAPO study.
1
In diabetic pregnancy, there are data indicating enhanced gene expression related to foeto-placental lipid metabolism, possibly increasing transplacental lipid delivery. 28 Placental hydrolysis of triglycerides could result in increased foetal free fatty acid levels leading to reesterification in foetal adipocytes. 29 In a recent study, Cade et al.
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demonstrated an increased rate of appearance of palmitate in obese women, particularly those with type 2 diabetes mellitus.
In this study, rates of glucose production and lipolysis were highly correlated and both related to maternal weight at assessment and resting energy expenditure. However, only glucose production was clearly related to fasting insulin. This suggests that the predisposition to insulin resistance predicts glucose substrate exposure to the foetus, whereas free fatty acid exposure may be more directly related to maternal fat mass.
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Our results are also in keeping with previous studies that have shown a relationship between resting energy expenditure and maternal weight gain and estimated foetal weight. 4 However, the relationship between GPR and lipolysis remained after adjusting for resting energy expenditure.
T A B L E 1 Maternal, foetal and infant characteristics and maternal glucose, glycerol kinetics and insulin levels There is a growing concern about increased maternal BMI and excess weight gain during pregnancy and the potential effect on the foetus and long-term implications for the offspring. This is a complex study both in terms of the population under investigation and the methodologies used and was therefore restricted to only a small number of participants.
A strength of the study is that ultrasound assessment of estimated foetal weight was performed at the time of the extensive physiological measurements. However, due to the limited size of the study population, conclusions cannot be drawn regarding individual components of the measures (biparietal diameter, femoral length and abdominal circumference) used in the estimation of foetal weight. 34 The lack of significant relationship between maternal rate of lipolysis and the size of the newborn infant could be attributed to the small number of mother-infant pairs in the context of variable placental function towards term, which would require further study. In model 1, estimated foetal weight was related to maternal variables. Total rate of glycerol production (lipolysis) was a significant factor in explaining estimated foetal weight at 35 wk. In model 2, total rate of glucose production was added as the second explanatory factor. 
EsƟmated foetal weight (g)
Rate of maternal whole-body glycerol producƟon (µmol/min) r = .72 P < .001
